No other corporate actions details are available.

IKIO Technologies, operating in the Consumer Electronics sector and classified as a Smallcap on the BSE, currently has its share price at ₹218.85. The stock has experienced fluctuations today ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

The 1261229 B.C. Ltd.-Bond has a maturity date of 4/15/2032 and offers a coupon of 10.0000%. The payment of the coupon will take place 2,0 times per biannual on the 15.10.. The 1261229 B.C. Ltd ...

The Canacol Energy Ltd.-Bond has a maturity date of 11/24/2028 and offers a coupon of 5.7500%. The payment of the coupon will take place 2,0 times per biannual on the 24.05.. At the current price ...

More Bonds of DP World Ltd. About the DP World Ltd.-Bond (XS1883878883) The DP World Ltd.-Bond has a maturity date of 9/25/2030 and offers a coupon of 4.2500%. The payment of the coupon will take ...

The GLP Pte. Ltd.-Bond has a maturity date of 6/4/2025 and offers a coupon of 3.8750%. The payment of the coupon will take place 2,0 times per biannual on the 04.12.. The GLP Pte. Ltd.-Bond was ...

More Bonds of Sekisui House Ltd. About the Sekisui House Ltd.-Bond (XS2919471156) The Sekisui House Ltd.-Bond has a maturity date of 10/23/2034 and offers a coupon of 5.1000%. The payment of the ...

The GFH Senior Sukuk Ltd.-Bond has a maturity date of 11/6/2029 and offers a coupon of 7.5000%. The payment of the coupon will take place 2,0 times per biannual on the 06.05.. The GFH Senior Sukuk ...

More Bonds of MTR Corporation Ltd. About the MTR Corporation Ltd.-Bond (HK0001127510) The MTR Corporation Ltd.-Bond has a maturity date of 4/2/2035 and offers a coupon of 4.8750%. The payment of ...

More Bonds of Mineral Resources Ltd. About the Mineral Resources Ltd.-Bond (USQ60976AB51) The Mineral Resources Ltd.-Bond has a maturity date of 11/1/2027 and offers a coupon of 8.0000%.

Rui Tostoes, Chief Technology Officer at ImmuneBridge, shares how his team is redefining preclinical development and large-scale manufacturing for allogeneic cell therapies. Advancing GPCR drug ...